Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development
Yeruk Mulugeta(United States Food and Drug Administration), Gilbert J. Burckart(Center for Drug Evaluation and Research), Dakshina Chilukuri(United States Food and Drug Administration), Abel Tilahun Eshete(United States Food and Drug Administration), Jeffrey S. Barrett(Aridhia (United Kingdom)), Dionna Green(United States Food and Drug Administration), Nicole Glasgow(University of Maryland, Baltimore), In‐Sook Kim(Frederick National Laboratory for Cancer Research), Robert M. Nelson(Johnson & Johnson (United States)), Lynne Yao(United States Food and Drug Administration), Andrew E. Mulberg, Shirley K. Seo(United States Food and Drug Administration), Daniel González(University of North Carolina at Chapel Hill), Kevin Krudys(United States Food and Drug Administration), Jeffry Florian(United States Food and Drug Administration), Alvina Mushtaq(Children's National)
Cited by 80
Related Papers
Clinical Pharmacokinetics of Tacrolimus
|Clinical Pharmacokinetics|1995|802
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
|Journal of Lipid Research|2007|595
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
|Carcinogenesis|2006|359
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Management of Childhood Onset Nephrotic Syndrome
|PEDIATRICS|2009|312